Antiphospholipid Syndrome (APS) is a major risk factor for pregnancy complications, yet diagnosing it remains challenging. Recent advancements in APS diagnostics provide deeper insights into its role in recurrent pregnancy loss and preeclampsia. Cutting-edge biomarker research and refined testing methods are improving accuracy, helping clinicians better identify at-risk patients and tailor treatment strategies. Discover the latest developments in APS diagnostics and their impact on maternal and fetal health.

Stay Ahead in Diagnostics and Subscribe to Our Medipan & GA Generic Assays‘ Newsletter In the fast-evolving field of diagnostics, staying informed is key. With the Medipan & GA Generic Assays newsletter, you gain exclusive access to our latest advancements, research insights, and innovative solutions in autoimmune and infectious disease diagnostics.  Why Subscribe?  As a […]

The International Consensus on ANA Patterns (ICAP) has taken another significant step in the continuous advancement to promote harmonization and understanding in antinuclear antibodies (ANA) of the HEp-2 IFA. As previously anticipated, in the ongoing update of the ANA pattern classification, two newly identified patterns, AC-30 and AC-31, have been incorporated into the ICAP nomenclature […]

A recent outbreak of Guillain-Barré Syndrome (GBS) in Pune, India, has seen approximately 160 reported cases since early January. The outbreak has been linked to Campylobacter jejuni, a foodborne pathogen and one of the leading causes of GBS worldwide1. Understanding Guillain-Barré Syndrome and Its Triggers GBS is a rare autoimmune disease where the immune system […]

Extended Shelf Life for Our RIA Kits We are pleased to announce that our optimized production processes now ensure you receive RIA Kits for Thyroid-Stimulating Hormone (TSH), Thyroglobulin (Tg), and Calcitonin detection with an extended shelf life of additional two weeks. Thanks to these improvements, we now complete the production process two weeks earlier, ensuring […]

Graves’ Disease Graves’ disease (GD) is a prevalent autoimmune thyroid disorder and the leading cause of hyperthyroidism, affecting up to 1% of the population. It stands as one of the most common autoimmune diseases globally. It arises when the immune system produces thyroid-stimulating hormone receptor antibodies (TRAb), which bind to and activate the thyroid-stimulating hormone […]

Discover our products of the line RIA and IRMA

September 5, 2024 | CCO Auditorium, Virchowweg 6, 10117 Berlin, Germany NeuroMiR will organize the MicroRNA Innovation Forum on September 5, 2024, at the CCO Auditorium in Berlin. This event provides an important platform to showcase groundbreaking advances in the early diagnosis of neurodegenerative diseases, with a special focus on Alzheimer’s disease. Attendees will have […]

Medipan & GA Generic Assays at the 14th International Congress on Autoimmunity 2024 in Ljubljana Some weeks ago, from May 17-19, 2024, we had the privilege of participating in the 14th International Congress on Autoimmunity in Ljubljana, Slovenia. This event brought together leading experts, researchers, and healthcare professionals to discuss the latest advancements in autoimmune […]

GA Generic Assays receives funding from the Just Transition Fund (JTF) We are very pleased that GA Generic Assays has received funding from the Just Transition Fund (JTF) for the expansion of our existing facility. The aim of this project is to expand our production of immunological test kits for the serological diagnosis of autoimmune […]